AOP Health Receives Market Authorization for Landiolol in Canada

[ad_1] Article content VIENNA — At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health…

DVSA to look at new eyesight law changes

[ad_1] The Driver and Vehicle Standards Agency (DVSA) has published its 2023–2024 business plan, which could see new rules around eyesight testing introduced. The plan states that the DVSA is…

AOP Health: Completed Study Strengthens Clinical Development Program for ropeginterferon alpha 2b (Besremi®) in polycythaemia vera

[ad_1] Article content VIENNA — With the publication of the final results from the LOW-PV study in the New England Journal of Medicine Evidence conducted by Fondazione per la Ricerca…